RT @RischZack
@TumorBoardTues @MPishvaian @JohnEbbenMDPhD @CCAlliance @shafiarahman_ @ASCO 4/22 #TumorBoardTuesdayMini tweetorial 2
RAS Mutation = resistance to anti-EGFR therapy
KRAS muts:
detected by NGS- tissue or liquid bx #ctDNA
≈49% of #CRC= KRAS/NRAS muts
KRAS codons 12 (30%) & 13 (~8%) of exon 2. NRAS (exons 2, 3, 4)https://pubmed.ncbi.nlm.nih.gov/26189770/